Browse > Article
http://dx.doi.org/10.15324/kjcls.2018.50.3.304

Regulatory T Cells Promote Pancreatic Islet Function and Viability via TGF-β1 in vitro and in vivo  

Choi, Bongkum (Transplantation Research Center, Clinical Research Institute, Samsung Biomedical Research Institute)
Kim, Sa-Hyun (Department of Clinical Laboratory Science, Semyung University)
Publication Information
Korean Journal of Clinical Laboratory Science / v.50, no.3, 2018 , pp. 304-312 More about this Journal
Abstract
Regulatory T cells (Treg), known as immune-suppressors, may help modulate the immune response. In this study, we investigated the effect of Treg-derived $TGF-{\beta}1$ on pancreatic islet cell function in vitro and in vivo. One hundred eighty IEQ (islet equivalents) of pancreatic islets, the marginal amount to regulate blood glucose level after syngeneic islet transplantation in mouse type 1 diabetes (T1D) model, were co-cultured with $4{\times}10^6$ Treg cells for 48 hours. The changes in $TGF-{\beta}1$, interleukin-6 (IL-6), and insulin secretion levels were measured and analyzed among the Treg-only group, the islet-only group, and the Treg/islet co-cultured group. In the Treg/islet co-cultured group, IL-6 and insulin secretion levels were increased (P<0.0005, P<0.005) and islet viability was improved (P<0.005) compared with the islet-only group. Furthermore, after transplantation, the co-cultured islets regulated blood glucose levels efficiently in the T1D mouse model. These data suggest that Treg could improve islet functions and viability via the $TGF-{\beta}1$ secretion pathway (P<0.05~0.005), thus the use of Treg in islet transplantation should be explored further.
Keywords
Interleukin 6; Islet; Regulatory T cell; TGF-beta; Transplantation;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Li MO, Wan YY, Sanjabi S, Robertson AK, Flavell RA. Transforming growth factor-beta regulation of immune responses. Annu Rev Immunol. 2006;24:99-146.   DOI
2 Letterio JJ, Roberts AB. Regulation of immune responses by TGF-$\beta$. Annu Rev Immunol. 1998;16:137-161.   DOI
3 Wahl SM. Transforming growth factor $\beta$: the good, the bad, and the ugly. J Exp Med. 1994;180:1587-1590.   DOI
4 Kehrl JH, Wakefield LM, Roberts AB, Jakowlew S, Alvarez-Mon M, Derynck R, et al. Production of transforming growth factor $\beta$ by human T lymphocytes and its potential role in the regulation of T cell growth. J Exp Med. 1986;163:1037-1050.   DOI
5 Chen Y, Kuchroo VK, Inobe J, Hafler DA, Weiner HL. Regulatory T cell clones induced by oral tolerance: suppression of autoimmune encephalomyelitis. Science. 1994;265:1237-1240.   DOI
6 Weiner HL. Induction and mechanism of action of transforming growth factor-$\beta$-secreting Th3 regulatory cells. Immunol Rev. 2001;182:207-214.   DOI
7 Nakamura K, Kitani A, Strober W. Cell contact-dependent immunosuppression by CD4+CD25+ regulatory T cells is mediated by cell surface-bound transforming growth factor $\beta$. J Exp Med. 2001;194:629-644.   DOI
8 Oida T, Zhang X, Goto M, Hachimura S, Totsuka M, Kaminogawa S, et al. CD4+CD25- Tcells that express latencyassociated peptide on the surface suppress CD4+CD45RBhighinduced colitis by a TGF-$\beta$-dependent mechanism. J Immunol. 2003;170:2516-2522.   DOI
9 Green EA, Gorelik L, McGregor CM, Tran EH, Flavell RA. CD4+CD25+ T regulatory cells control anti-islet CD8+ T cells through TGF-$\beta$ receptor interactions in type 1 diabetes. Proc Natl Acad Sci. 2003;100:10878-10883.   DOI
10 Piccirillo CA, Letterio JJ, Thornton AM, McHugh RS, Mamura M, Mizuhara H, et al. CD4+CD25+ regulatory T cells can mediate suppressor function in the absence of transforming growth factor $\beta$1 production and responsiveness. J Exp Med. 2002; 196:237-246.   DOI
11 Nakamura K, Kitani A, Fuss I, Pedersen A, Harada N, Nawata H, et al. TGF-$\beta$1 plays an important role in the mechanism of CD4+CD25+ regulatory T cell activity in both humans and mice. J Immunol. 2004;172:834-842.   DOI
12 Powrie F, Carlino J, Leach MW, Mauze S, Coffman RL. A critical role for transforming growth factor-$\beta$ but not interleukin 4 in the suppression of T helper type 1-mediated colitis by CD45RB(low) CD4+ T cells. J Exp Med. 1996;183:2669-2674.   DOI
13 Mamura M, Lee W, Sullivan TJ, Felici A, Sowers AL, Allison JP, Letterio JJ. CD28 disruption exacerbates inflammation in TGF-$\beta$1-/- mice: in vivo suppression by CD4+CD25+ regulatory T cells independent of autocrine TGF-$\beta$1. Blood. 2004; 103:4594-601.   DOI
14 Fahlen L, Read S, Gorelik L, Hurst SD, Coffman RL, Flavell RA, et al. T cells that cannot respond to TGF-$\beta$ escape control by CD4+CD25+regulatory T cells. J Exp Med. 2005;201:737-746.   DOI
15 Namba K, Kitaichi N, Nishida T, Taylor AW. Induction of regulatory T cells by the immunomodulating cytokines alpha-melanocyte-stimulating hormone and transforming growth factor-beta2. J Leukoc Biol. 2002;72:946-952.
16 Fantini MC, Becker C, Monteleone G, Pallone F, Galle PR, Neurath MF. Cutting edge: TGF-beta induces a regulatory phenotype in CD4+CD25- T cells through Foxp3 induction and down-regulation of Smad7. J Immunol. 2004;172:5149-5153.   DOI
17 Tonkin DR, Haskins K. Regulatory T cells enter the pancreas during suppression of type 1 diabetes and inhibit effector T cells and macrophages in a TGF-beta-dependent manner. Eur J Immunol. 2009;39:1313-1322.   DOI
18 Calderon B, Suri A, Pan XO, Mills JC, Unanue ER. IFN-gamma-dependent regulatory circuits in immune inflammation highlighted in diabetes. J Immunol. 2008;181:6964-6974.   DOI
19 Tran DQ, Ramsey H, Shevach EM. Induction of FOXP3 expression in naive human CD4+FOXP3 T cells by T-cell receptor stimulation is transforming growth factor-beta dependent but does not confer a regulatory phenotype. Blood. 2007;110: 2983-2990.   DOI
20 Lin HM, Lee JH, Yadav H, Kamaraju AK, Liu E, Zhigang D, et al. Transforming growth factor-beta/Smad3 signaling regulates insulin gene transcription and pancreatic islet beta-cell function. J Biol Chem. 2009;284:12246-12257.   DOI
21 Zang W, Lin M, Kalache S, Zhang N, Kruger B, Waaga-Gasser AM, et al. Inhibition of the alloimmune response through the generation of regulatory T cells by a MHC class II-derived peptide. J Immunol. 2008;181:7499-7506.   DOI
22 Simeone DM, Zhang L, Treutelaar MK, Zhang L, Graziano K, Logsdon CD, et al. Islet hypertrophy following pancreatic disruption of Smad4 signaling. Am J Physiol Endocrinol Metab. 2006;291:E1305-1316.   DOI
23 Sabek OM, Fraga DW, Henry J, Gaber LW, Kotb M, Gaber AO, et al. Expression of transforming growth factor $\beta$ by human islets: impact on islet viability and function. Cell Transplantation. 2007;16:775-785.   DOI
24 Chao KC, Chao KF, Chen CF, Liu SH. A novel human stem cell coculture system that maintains the survival and function of culture islet-like cell clusters. Cell Transplant. 2008;17: 657-664.   DOI
25 Choi SE, Choi KM, Yoon IH, Shin JY, Kim JS, Park WY, et al. IL-6 protects pancreatic islet beta cells from pro-inflammatory cytokines-induced cell death and functional impairment in vitro and in vivo. Transpl Immunol. 2004;13:43-53.   DOI
26 Kamimura D, Ishihara K, Hirano T. IL-6 signal transduction and its physiological roles: the signal orchestration model. Rev Physiol Biochem Pharmacol. 2003;149:1-38.
27 Birkey Reffey S, Wurthner JU, Parks WT. X-linked inhibitor of apoptosis protein functions as a cofactor in transforming growth factor-$\beta$ signaling. J Biol Chem. 2001;276:26542-26549.   DOI
28 Sayo Y, Hosokawa H, Imachi H, Murao K, Sato M, Wong NC, et al. Transforming growth factor $\beta$ induction of insulin gene expression in mediated by pancreatic and duodenal homeobox gene-1 in rat insulinoma cells. Eur J Biochem. 2000;267: 971-978.   DOI